FOR YOUR LOVED ONE WITH DRAVET SYNDROME OR LENNOX-GASTAUT SYNDROME (LGS) AGED 2 YEARS AND OLDER

Steps to getting FINTEPLA

FINTEPLA can fit into your loved one’s treatment plan

Lucas, living with LGS

FINTEPLA is a twice-daily oral solution that is compatible with feeding tubes and has no dietary restrictions, including being on the ketogenic diet.

FINTEPLA works with your loved one’s current treatment plans. It can be added without making a change to existing antiseizure medicines.*†

FINTEPLA can be added without making changes to current antiseizure medicines.*

Plus, when a patient starts FINTEPLA, they may be able to stay on their current antiseizure treatment plan.*†

Though your loved one’s current antiseizure treatment plan does not need to be adjusted when adding FINTEPLA, the maximum daily dose of FINTEPLA may need to be adjusted if your loved one is also taking certain other therapeutic medicines or has certain other medical conditions.

Dravet syndrome patients adding FINTEPLA should start at the 0.2 mg/kg/day dose and increase each week based on efficacy and tolerability until they reach the maintenance dose recommended by their healthcare provider.

LGS patients adding FINTEPLA should start at the 0.2 mg/kg/day dose and increase weekly based on tolerability to a maximum recommended maintenance dose of 0.7 mg/kg/day. In the LGS clinical study, 0.7 mg/kg/day was the dose of FINTEPLA to significantly reduce monthly drop seizures.

*Patients should not take FINTEPLA if they are allergic to fenfluramine or any of the ingredients in FINTEPLA, or if they have taken medicines called monoamine oxidase inhibitors (MAOIs) in the last 14 days. This may cause a serious or life-threatening problem called serotonin syndrome. If you are not sure whether or not they are taking one of these medicines, contact your healthcare provider.

Talk to your loved one’s healthcare provider about all of their medical conditions and medicines they take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

If you are ready to try something different with FINTEPLA, there are a few steps you can take to start the process.

Talk to your healthcare provider about the potential risks and benefits of FINTEPLA and about enrolling in the FINTEPLA REMS Program.

Call 1-888-ZOGENIX (1-888-964-3649) to connect with Zogenix Central and ask to speak with a Clinical Nurse Educator for education, resources, and support as you get started.

Clinical Nurse Educators are here to help before and during treatment with FINTEPLA

Your loved one’s healthcare provider is your first source of information, but the FINTEPLA Clinical Nurse Educators can help answer your questions, as well. They are registered nurses who can help you make informed decisions about treatment with FINTEPLA and prepare for a conversation with your loved one’s healthcare provider.

To have a live, one-on-one conversation, call 1-888-ZOGENIX (1-888-964-3649) and ask to speak with a Clinical Nurse Educator.

Frequently Asked Questions

In clinical studies, FINTEPLA was proven to significantly reduce seizures caused by Dravet syndrome or LGS in patients 2 years of age and older.*

To help you learn more about FINTEPLA, see below for answers to commonly asked questions. When you’re ready, talk to your healthcare provider to decide if FINTEPLA is right for you or your loved one.

What is FINTEPLA?

FINTEPLA is a prescription medicine used to treat the seizures associated with Dravet syndrome and LGS in patients 2 years of age and older.

How is FINTEPLA taken?

FINTEPLA is a cherry-flavored liquid that is taken by mouth (administered orally) and can be taken with or without food. Read the Instructions for Use at the end of the FINTEPLA Medication Guide for information on the right way to take FINTEPLA.

How can my loved one get on FINTEPLA?

FINTEPLA is available only through the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) Program. In the past, some adults who took fenfluramine, the active ingredient in FINTEPLA, developed problems with their heart valves or high blood pressure in the arteries of their lungs. The FINTEPLA REMS is designed to help manage these potential safety concerns.

Before your loved one receives FINTEPLA, your healthcare provider will check their heart valves and lung artery pressure with a test called an echocardiogram (echo), which is an ultrasound picture of the heart. After enrolling in the FINTEPLA REMS and reviewing your loved one’s echo results, you and your healthcare provider will decide whether to begin FINTEPLA.

Did patients in the FINTEPLA clinical studies develop problems with the heart valves or high blood pressure in the arteries of the lungs?

Of the 604 patients who have taken FINTEPLA in clinical trials to date, none have developed problems with the valves in the heart or blood pressure in the arteries of the lungs. This includes some patients who have been treated for up to 3 years. However, the FINTEPLA REMS program can help identify these potential problems early before symptoms begin to develop.

None of the 603 patients who took FINTEPLA during the clinical studies developed problems with their heart valves that caused valvular heart disease or high blood pressure in the arteries of the lungs, including patients treated for up to 3 years. However, the FINTEPLA REMS can help to identify any problems before symptoms develop.

Is financial assistance available for FINTEPLA?

Zogenix is committed to making FINTEPLA affordable and accessible for all patients and sponsors several financial assistance programs, including the Zogenix Copay Support Program and the Zogenix Patient Support Program.

For more information about these financial assistance programs, please call Zogenix Central at 1-888-ZOGENIX (1-888-964-3649).

Can FINTEPLA be taken with other antiseizure medications?

During clinical studies, patients were on their current treatment plans, including other antiseizure medicines or treatments, such as use of a vagal nerve stimulator or ketogenic diet, while taking FINTEPLA. If you have additional questions about taking other medicines with FINTEPLA, speak with your healthcare provider.

Can FINTEPLA be taken with cannabidiol (CBD)?

Yes. FINTEPLA can be taken with commercially available CBD. If you have additional questions, speak with your healthcare provider.

Can FINTEPLA be taken while on a ketogenic diet?

Yes. There are no restrictions for use of FINTEPLA while on a ketogenic diet. In fact, patients on a ketogenic diet were included in the FINTEPLA clinical trials. Remember to discuss with your healthcare provider all treatments you may be taking, including the ketogenic diet.

Can FINTEPLA be taken with feeding tubes?

Yes. FINTEPLA is compatible with feeding tubes. If you have additional questions, speak with your healthcare provider.

What are the most common side effects of FINTEPLA?

For patients with Dravet syndrome treated with FINTEPLA (0.7 mg/kg/day), the most common side effects include: decreased appetite; diarrhea; low energy; respiratory infection; decreased weight; fever; constipation; abnormal echocardiogram; sleepiness; problems with movement, balance, and walking; increased drooling; increased blood pressure; vomiting; falls; seizures that do not stop; weakness.

For patients with LGS treated with FINTEPLA (0.7 mg/kg/day), the most common side effects include: diarrhea; tiredness; vomiting; sleepiness; decreased appetite.

Some patients in the clinical studies experienced a decrease in appetite and weight. However, most patients with Dravet syndrome and approximately half of patients with LGS resumed expected weight gains during the open-label extension study. If you have additional questions, speak with your healthcare provider.

Explore what FINTEPLA has to offer

Get downloadable brochures for Dravet syndrome and LGS to see seizure reduction results, studies, and more—all in one place.

Financial support for FINTEPLA

Zogenix is dedicated to making FINTEPLA available and affordable for every eligible patient.

Stay Informed

Register below to receive news and updates about FINTEPLA and Dravet syndrome or Lennox-Gastaut syndrome (LGS).

The fields marked with an asterisk (*) are mandatory.

Please fill out this section to continue
Please fill out this section to continue
Please fill out this section to continue

I am interested in learning more about*:

Please select one.

Indication

  • FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older.
  • FINTEPLA is a federally controlled substance (C-IV) because it contains fenfluramine. Keep FINTEPLA in a safe place to prevent misuse, abuse, and protect it from theft. Never give your FINTEPLA to anyone else, because it may harm them. Selling or giving away this medicine is against the law. Tell your healthcare provider if you have abused or been dependent on alcohol, prescription medicines, or street drugs.
  • It is not known if FINTEPLA is safe and effective in children less than 2 years of age.

Important Safety Information

FINTEPLA can cause serious side effects, including:

  1. 1.Problems with the valves in the heart (valvular heart disease) and high blood pressure in the arteries of the lungs (pulmonary arterial hypertension) have been associated with fenfluramine, the active ingredient in FINTEPLA. Your healthcare provider will do a test called an echocardiogram to check your heart and to evaluate for high blood pressure in the arteries of the lungs before you start taking FINTEPLA, again every 6 months during treatment, and one time 3 to 6 months after you take your last dose of FINTEPLA.

    Call your healthcare provider right away if you develop any of these signs and symptoms of heart or lung problems during treatment with FINTEPLA:

    • shortness of breath
    • tiredness or weakness, especially with increased activity
    • lightheadedness or fainting
    • swollen ankles or feet
    • chest pain
    • sensations of a rapid, fluttering heartbeat (palpitations)
    • irregular pulse
    • bluish color of your lips and skin (cyanosis)

    Because of the risk of heart valve problems (valvular heart disease) and high blood pressure in arteries of lungs (pulmonary arterial hypertension), FINTEPLA is only available through a restricted program called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) Program. Before you or your child receives FINTEPLA, your healthcare provider or pharmacist will make sure you understand how to take FINTEPLA safely. If you have any questions about FINTEPLA, ask your healthcare provider, visit www.FinteplaREMS.com, or call 1-877-964-3649.

  2. 2. Decreased appetite and decreased weight. Decreased appetite and decreased weight are both serious and common side effects of FINTEPLA in people with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS).

    • Your weight should be checked regularly during your treatment with FINTEPLA.
    • Your healthcare provider may need to make changes to your FINTEPLA dose if your weight decreases. In some cases, FINTEPLA may need to be stopped.
  3. 3. Sleepiness, sedation, and lack of energy (lethargy). These are both serious and common side effects of FINTEPLA in people with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS). Taking FINTEPLA with central nervous system (CNS) depressants, including alcohol, may increase sleepiness. Do not drive, operate heavy machinery, or do other dangerous activities until you know how FINTEPLA affects you.

  4. 4. Like all other antiepileptic drugs, FINTEPLA may cause suicidal thoughts or actions in a very small number of people (about 1 in 500).

    Call your healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you:

    • thoughts about suicide or dying
    • trouble sleeping (insomnia)
    • attempts to commit suicide
    • new or worse irritability
    • new or worse depression
    • acting aggressive, being angry or violent
    • new or worse anxiety
    • acting on dangerous impulses
    • feeling agitated or restless
    • an extreme increase in activity and talking (mania)
    • panic attacks
    • other unusual changes in behavior or mood

    How can I watch for early symptoms of suicidal thoughts and actions?

    • Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings.
    • Keep all follow-up visits with your healthcare provider as scheduled.

    Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes.

  5. 5. Do not stop taking FINTEPLA without first talking to your healthcare provider. Stopping a seizure medicine such as FINTEPLA can suddenly cause you to have seizures more often or seizures that do not stop (status epilepticus).

    Call your healthcare provider between visits as needed, especially if you are worried about symptoms.

    Do not take FINTEPLA if you:

    • are allergic to fenfluramine or any of the ingredients in FINTEPLA. See below for a complete list of ingredients in FINTEPLA.
    • are taking or have stopped taking medicines called monoamine oxidase inhibitors (MAOIs) in the last 14 days. This may cause a serious or life-threatening problem called serotonin syndrome. If you are not sure whether or not you are taking one of these medicines, contact your healthcare provider.

    Before taking FINTEPLA, tell your healthcare provider about all of your medical conditions, including if you:

    • have heart problems
    • have or have had weight loss
    • have or have had depression, mood problems, or suicidal thoughts or behavior
    • have kidney problems
    • have liver problems
    • are pregnant or plan to become pregnant. Tell your healthcare provider right away if you become pregnant while taking FINTEPLA. You and your healthcare provider will decide if you should take FINTEPLA while you are pregnant.
      • If you become pregnant while taking FINTEPLA, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy Registry. You can enroll in this registry by calling 1-888-233-2334 or go to www.aedpregnancyregistry.org. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy.
    • are breastfeeding or plan to breastfeed. It is not known if FINTEPLA passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking FINTEPLA.

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.

    How should I take FINTEPLA?

    • Read the Instructions for Use for information on the right way to use FINTEPLA.
    • Take FINTEPLA exactly as your healthcare provider tells you to take it.
    • Your healthcare provider will tell you how much FINTEPLA to take and when to take it.
    • FINTEPLA may be taken with or without food.
    • Measure your dose of FINTEPLA using the dosing syringe that is provided by the pharmacy. Do not use a household teaspoon or tablespoon.
    • FINTEPLA can be given through gastric and nasogastric feeding tubes.

    What should I avoid while taking FINTEPLA?

    • Do not drive, operate heavy machinery, or do other dangerous activities until you know how FINTEPLA affects you. FINTEPLA may cause you to feel sleepy.

    What are the possible side effects of FINTEPLA?

    FINTEPLA may cause serious side effects, including:
    • See “FINTEPLA can cause serious side effects” above
      • Serotonin syndrome. Serotonin syndrome is a life-threatening problem that can happen in people taking FINTEPLA, especially if FINTEPLA is taken with certain other medicines including: anti-depressant medicines called SSRIs, SNRIs, TCAs, and MAOIs; tryptophan; lithium; antipsychotics; St. John’s Wort; dextromethorphan; tramadol. Call your healthcare provider right away if you have any of the following symptoms of serotonin syndrome:
        • mental status changes such as seeing things that are not there (hallucinations), agitation, or coma
        • changes in blood pressure
        • tight muscles
        • fast heartbeat
        • nausea, vomiting, diarrhea
        • high body temperature
        • trouble walking
      • High blood pressure (hypertension). Hypertension is both a serious and common side effect. FINTEPLA can cause your blood pressure to increase even if you have never had high blood pressure before. Your healthcare provider will check your blood pressure while you are taking FINTEPLA.
      • Increased pressure in your eyes (glaucoma). Symptoms of glaucoma may include:
        • red eyes
        • seeing halos or bright colors around lights
        • nausea or vomiting
        • decreased vision
        • eye pain or discomfort
        • blurred vision

    If you have any of these symptoms, call your healthcare provider right away.

    • The most common side effects of FINTEPLA when used to treat Dravet syndrome (DS) include:
      • decreased appetite
      • diarrhea
      • low energy
      • respiratory infection
      • decreased weight
      • fever
      • constipation
      • abnormal echocardiogram
      • sleepiness
      • problems with movement, balance, and walking
      • increased drooling
      • increased blood pressure
      • vomiting
      • falls
      • seizures that do not stop
      • weakness
    • The most common side effects of FINTEPLA when used to treat Lennox-Gastaut syndrome (LGS) include:
      • diarrhea
      • tiredness
      • vomiting
      • sleepiness
      • decreased appetite

These are not all the possible side effects of FINTEPLA. For more information, ask your healthcare provider or pharmacist. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Keep FINTEPLA and all medicines out of the reach of children.

General information about the safe and effective use of FINTEPLA.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use FINTEPLA for a condition for which it was not prescribed. Do not give FINTEPLA to other people, even if they have the same symptoms that you have. It may harm them.

What are the ingredients in FINTEPLA?

Active ingredient: fenfluramine hydrochloride

Inactive ingredients:
  • cherry flavor
  • citric acid
  • ethylparaben
  • hydroxyethylcellulose
  • methylparaben
  • potassium citrate
  • sucralose
  • and water.

FINTEPLA contains no ingredient made from gluten-containing grain (wheat, barley, or rye) and contains not more than 0.1% of carbohydrates, which is from the cherry flavoring.

Please see full Prescribing Information, including Medication Guide, for additional Important Safety Information on FINTEPLA.